In this study, we aimed to identify KIT and NTRK1 (which encodes TrkA protein) gene expression patterns in pediatric patients with NB and AML (from publicly available datasets) and reveal the hallmarks of the high and low expressions of those genes. This evidence concerns the gene NTRK1 and neuroblastoma.